Cargando…

Atractylenolide I inhibits antibiotic-induced dysbiosis of the intestinal microbiome

BACKGROUND: Atractylenolide I (AT-I) is an active component that is isolated from Rhizoma Atractylodis macrocephalae and it exerts anti-apoptotic, anti-oxidant, and anti-coagulant properties, and has been widely applied in the treatment of cardiovascular and cerebrovascular diseases in China. This s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Penglin, Zhao, Gang, Zhang, Lize, Gong, Yuxia, Gu, Yunfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576645/ https://www.ncbi.nlm.nih.gov/pubmed/34790745 http://dx.doi.org/10.21037/atm-21-4656

Ejemplares similares

UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
por: Xu, Shizhao, et al.
Publicado: (2018)

Atractylenolide-I covalently binds to CYP11B2, selectively inhibits aldosterone synthesis, and improves hyperaldosteronism
por: Liu, Wenjuan, et al.
Publicado: (2022)

Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis
por: Hagihara, Mao, et al.
Publicado: (2019)

Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2016)

Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles
por: Fan, Meng, et al.
Publicado: (2022)

Atractylenolide I alleviates ischemia/reperfusion injury by preserving mitochondrial function and inhibiting caspase-3 activity
por: Sun, Caiqin, et al.
Publicado: (2021)

Lentinan improves intestinal inflammation and gut dysbiosis in antibiotics-induced mice
por: Ji, Xiuyu, et al.
Publicado: (2022)

Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells
por: Long, Fangyi, et al.
Publicado: (2017)

Correction to: Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2018)

Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
por: More, Sandeep, et al.
Publicado: (2017)

Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro
por: Chan, Ka Woon Karen, et al.
Publicado: (2020)

A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients
por: Liu, Yi, et al.
Publicado: (2008)

Atractylenolide III inhibits epithelial-mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway
por: Huang, Mingjin, et al.
Publicado: (2022)

Alteration of gut microbiome and metabolome by Clostridium butyricum can repair the intestinal dysbiosis caused by antibiotics in mice
por: Liu, Xin, et al.
Publicado: (2023)

Microbiome dysbiosis inhibits carcinogen-induced murine oral tumorigenesis
por: Chen, Yuh-Ling, et al.
Publicado: (2022)

Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27
por: Qiao, Pengfei, et al.
Publicado: (2023)

Change in intestinal alkaline phosphatase activity is a hallmark of antibiotic-induced intestinal dysbiosis
por: Dissanayake, Wijesooriya Mudhiyanselage Nadeema, et al.
Publicado: (2023)

Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
por: Zhang, Wan-li, et al.
Publicado: (2019)

Anti-Tumor Effects of Atractylenolide I Isolated from Atractylodes macrocephala in Human Lung Carcinoma Cell Lines
por: Liu, Huanyi, et al.
Publicado: (2013)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

Transfer of metastatic traits via miR‐200c in extracellular vesicles derived from colorectal cancer stem cells is inhibited by atractylenolide I
por: Tang, Dongxin, et al.
Publicado: (2020)

Atractylenolide I Induces Apoptosis and Suppresses Glycolysis by Blocking the JAK2/STAT3 Signaling Pathway in Colorectal Cancer Cells
por: Li, Yanxi, et al.
Publicado: (2020)

Dysbiosis in intestinal microbiome linked to fecal blood determined by direct hybridization
por: Cafiero, Concetta, et al.
Publicado: (2020)

Atractylenolide I inhibited the development of malignant colorectal cancer cells and enhanced oxaliplatin sensitivity through the PDK1-FoxO1 axis
por: Sun, Ye, et al.
Publicado: (2022)

Atractylenolide II Inhibits Proliferation, Motility and Induces Apoptosis in Human Gastric Carcinoma Cell Lines HGC-27 and AGS
por: Tian, Shuang, et al.
Publicado: (2017)

Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Dysbiosis of the Gut Microbiome Is Associated With Histopathology of Lung Cancer
por: Qin, Xiong, et al.
Publicado: (2022)

Long-term dysbiosis and fluctuations of gut microbiome in antibiotic treated preterm infants
por: Cetinbas, Murat, et al.
Publicado: (2023)

Insight into the gut microbiome dysbiosis in patients with liver failure after extended-hepatectomy
por: Xie, Feihu, et al.
Publicado: (2022)

Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
por: Wipperman, Matthew F., et al.
Publicado: (2017)

Fiber supplementation protects from antibiotic-induced gut microbiome dysbiosis by modulating gut redox potential
por: Penumutchu, Swathi, et al.
Publicado: (2023)

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
por: Saltzman, Emma T., et al.
Publicado: (2018)

The Relationship of Tumor Microbiome and Oral Bacteria and Intestinal Dysbiosis in Canine Mammary Tumor
por: Zheng, Hui-Hua, et al.
Publicado: (2022)

Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review
por: Xie, Zhiyi, et al.
Publicado: (2023)

Atractylenolide-I Suppresses Tumorigenesis of Breast Cancer by Inhibiting Toll-Like Receptor 4-Mediated Nuclear Factor-κB Signaling Pathway
por: Long, Fangyi, et al.
Publicado: (2020)

Atractylenolide I Inhibits NLRP3 Inflammasome Activation in Colitis-Associated Colorectal Cancer via Suppressing Drp1-Mediated Mitochondrial Fission
por: Qin, Yao, et al.
Publicado: (2021)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
por: Wang, Meng, et al.
Publicado: (2021)

P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells
por: Han, Yue, et al.
Publicado: (2022)

Dysbiosis of the microbiome in gastric carcinogenesis
por: Castaño-Rodríguez, Natalia, et al.
Publicado: (2017)

Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice
por: Yang, Ning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g0fuos6fgq6f9ld1k76b5qk7bd